mas-1 adjuvanted insulin b-chain
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 4, 2018 (NCT03624062)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- InsulinImmunity, desensitized
INS immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03624062 | Phase 1 | Sep 4, 2018 | Nova Immunotherapeutics Limited, The Leona M. and Harry B. Helmsley Charitable Trust, University of Colorado, Denver |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nova Immunotherapeutics Limited | For profit | 1 | 0 | 1 | 2018 |
| The Leona M. and Harry B. Helmsley Charitable Trust | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Colorado, Denver | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1